The city of Syracuse, New York, currently has 1 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies.
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
Recruiting
A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of MN-166 given to ALS participants for 12 months followed by a 6-month open-label extension phase.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
06/19/2024
Locations: SUNY Upstate Medical University, Syracuse, New York
Conditions: Amyotrophic Lateral Sclerosis